Assessing Safety and Tolerability in Bee Venom Immunotherapy: Conventional vs. 1-day Ultra Rush Protocol

Files

Authors

Connor Kuipers, Corewell Health West Resident
Kaylee Gwyn, Michigan State University College of Human Medicine Medical Student
Ted Kelbel, Corewell Health West

Description

Venom immunotherapy (VIT) is a potentially lifesaving treatment for patients with anaphylaxis to Hymenoptera. Research comparing the safety and tolerability of the conventional weekly build-up protocol with single day ultra-rush protocol is limited.

Publication Date

5-9-2025

Recommended Citation

Kuipers C, Gwyn K, Kelbel T. Assessing safety and tolerability in bee venom immunotherapy: Conventional vs. 1-day ultra rush protocol. Presented at: Research Day Corewell Health West; 2025 May 9; Grand Rapids, MI.

Comments

2025 Research Day Corewell Health West, Grand Rapids, MI, May 9, 2025. Abstract 1681